Hayat Biotech
Research - أبو ظبي, أبو ظبي, United Arab Emirates
Hayat Biotech Details
Hayat Biotech, a UAE-based Biotech entity was established in 2021 as a joint venture between Sinopharm CNBG and G42. Created with the aim to deliver innovative biotechnological capabilities to the globe, we consistently challenge the barriers of science in determination to elevate the standards of life. Hayat Biotech has already broken ground by clinical development, manufacturing, and deployment of Hayat-Vax with a production capacity of up to 6.5 million doses a month.A state of the art, purpose-built R&D and global distribution hub for life sciences, biotechnology and vaccine production will escalate Hayat Biotech's production capacity to 200 million doses per annum.
Hayat Biotech Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Other
Mobile Friendly